336 studies found for:    Spasticity
Show Display Options
Rank Status Study
21 Recruiting Dose-response Study of Efficacy and Safety of Botulinum Toxin Type A to Treat Spasticity of the Arm(s) or of Arm(s) and Leg(s) in Cerebral Palsy
Conditions: Cerebral Palsy;   Spasticity
Interventions: Drug: IncobotulinumtoxinA (8 Units per kg body weight);   Drug: IncobotulinumtoxinA (6 Units per kg body weight);   Drug: IncobotulinumtoxinA (2 Units per kg body weight)
22 Completed MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A;   Drug: Botulinum Toxin type A
23 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Due to Spinal Cord Injury
Condition: Muscle Spasticity
Interventions: Drug: tolperisone HCl (AV650);   Drug: Placebo
24 Completed The Use of Penile Vibratory Stimulation to Decrease Spasticity Following Spinal Cord Injury
Conditions: Spinal Cord Injury;   Muscle Spasticity
Intervention: Procedure: Penile Vibratory Stimulation
25 Terminated Safety and Preliminary Effectiveness of AV650 in Patients With Spasticity Associated With Multiple Sclerosis
Condition: Muscle Spasticity
Intervention: Drug: tolperisone HCl
26 Active, not recruiting One Year, Open Label, Dose Escalation Long-term Safety Study in Multiple Sclerosis (MS) Subjects With Spasticity
Conditions: Multiple Sclerosis;   Spasticity
Intervention: Drug: arbaclofen
27 Not yet recruiting Phase 3, 28-week, Randomized, Double-blind, Placebo-controlled Safety and Efficacy Study of Nabiximols as an add-on Therapy in Subjects With Spasticity Due to Multiple Sclerosis.
Conditions: Spasticity;   Multiple Sclerosis
Interventions: Drug: Sativex;   Drug: Placebo
28 Unknown  Energy Costs of Spasticity in Spinal Cord Injury: A Pilot Investigation
Conditions: Basal Energy Expenditure;   Spasticity
Intervention: Other: Weaning of Antispasticity Medication
29 Recruiting Long-term Open-label Study of Botulinumtoxin Type A to Treat Spasticity of Leg(s) or Leg(s) and Arm in Cerebral Palsy
Condition: Lower Limb and Combined Lower Limb and Upper Limb Spasticity Due to Cerebral Palsy
Intervention: Drug: IncobotulinumtoxinA (16-20 Units per kg body weight)
30 Recruiting Safety of Xeomin for Lower Limb Spasticity in Multiple Sclerosis Patients
Conditions: Muscle Spasticity;   Multiple Sclerosis
Interventions: Biological: incabotulinumtoxinA;   Biological: Placebo
31 Completed Physiologic Studies of Spasticity
Conditions: Muscle Spasticity;   Healthy
Intervention:
32 Recruiting A Safety, Efficacy and Tolerability Study of Sativex for the Treatment of Spasticity in Children Aged 8 to 18 Years
Condition: Cerebral Palsy
Interventions: Drug: Sativex;   Drug: Placebo
33 Completed Asian Botulinum Clinical Trial Designed for Early Stroke Spasticity
Conditions: Muscle Spasticity;   Cerebrovascular Accident
Interventions: Drug: Botulinum toxin type A (Dysport®);   Other: Placebo
34 Completed Prevalence of Spasticity in Adults With Mental Retardation Living in the Community
Conditions: Mental Retardation;   Spasticity
Intervention:
35 Recruiting Action of Baclofen Capsules in Spasticity Due to Multiple Sclerosis
Condition: Spasticity
Interventions: Drug: Baclofen dose 1;   Drug: Baclofen dose 2;   Drug: Placebo
36 Completed
Has Results
Efficacy and Safety Study of Botulinum Neurotoxin A With Rehabilitation Versus Botulinum Neurotoxin A Alone in Treatment of Post-stroke Spasticity
Condition: Upper Limb Spasticity
Interventions: Drug: Botulinum toxin type A, BoNT-A;   Other: Rehabilitation Therapy
37 Completed
Has Results
A Multicenter, Open-label, Single Dose Study of the Safety and Efficacy of GSK1358820 (Botulinum Toxin Type A) in Chinese Subjects With Post-stroke Focal Upper Limb Spasticity
Condition: Spasticity, Post-Stroke
Intervention: Drug: Botulinum toxin type A
38 Completed Trial Comparing Two Commercial Formulations of Botulinum Toxin Type A in the Treatment of Spasticity
Condition: Spasticity
Interventions: Drug: Botulinum toxin type A from laboratory Lanzhou;   Drug: Botulinum toxin type A from laboratory Allergan
39 Completed Comparison of Safety and Efficacy of Tizanidine Hydrochloride Capsules Versus Zanaflex® (Tizanidine Hydrochloride Tablets) Taken While in the Fed State (Just After a Meal) and in the Fasted State (Before a Meal) in Patients With Moderate to Severe Spasticity.
Conditions: Multiple Sclerosis;   Muscle Spasticity;   Spinal Cord Injury;   Stroke
Intervention: Drug: tizanidine hydrochloride capsule
40 Active, not recruiting Study of a New Generation Botulinum Toxin A2NTX to Treat Spasticity After Stroke
Condition: Lower Limb Spasticity After Stroke
Interventions: Drug: A2NTX;   Drug: BOTOX

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years